News - Page 38 - Psychedelic Alpha

Read more about the article Optimi Health To Supply MDMA For Therapist Experiential Training Program at Numinus, Supported by MAPS

Optimi Health To Supply MDMA For Therapist Experiential Training Program at Numinus, Supported by MAPS

Post published:June 15, 2023
Post category:Press Release

Read more about the article Numinus Announces Partnership with MAPS to Support Therapist Psychedelic Experiential Training

Numinus Announces Partnership with MAPS to Support Therapist Psychedelic Experiential Training

Post published:June 15, 2023
Post category:Press Release

Read more about the article Psychedelic Bulletin #139: Kentucky Earmarks $42m for Ibogaine Studies; Reunion Announces Take-Private Deal; Compass Patents Upheld; Theories of Psychedelics’ Mechanism of Action

Psychedelic Bulletin #139: Kentucky Earmarks $42m for Ibogaine Studies; Reunion Announces Take-Private Deal; Compass Patents Upheld; Theories of Psychedelics’ Mechanism of Action

Post published:June 14, 2023
Post category:Psychedelic Bulletin

Read more about the article Numinus Appoints New Chief Financial Officer

Numinus Appoints New Chief Financial Officer

Post published:June 14, 2023
Post category:Press Release

Read more about the article Silo Pharma Signs Agreement to Develop First-in-Class Ketamine Implant Therapeutic

Silo Pharma Signs Agreement to Develop First-in-Class Ketamine Implant Therapeutic

Post published:June 13, 2023
Post category:Press Release

Read more about the article PharmaTher Holdings Provides Corporate Update

PharmaTher Holdings Provides Corporate Update

Post published:June 12, 2023
Post category:Press Release

Read more about the article Delix Therapeutics Appoints Aaron Koenig, MD as Chief Medical Officer

Delix Therapeutics Appoints Aaron Koenig, MD as Chief Medical Officer

Post published:June 12, 2023
Post category:Press Release

Read more about the article Wesana Health Announces Voting Results of AGSM

Wesana Health Announces Voting Results of AGSM

Post published:June 9, 2023
Post category:Press Release

Read more about the article Apex Labs Receives Approval for US-Based Secondary GMP Psilocybin Supplier by Health Canada

USA – English

USA – English

Apex Labs Receives Approval for US-Based Secondary GMP Psilocybin Supplier by Health Canada USA – English USA – English

Post published:June 9, 2023
Post category:Press Release

Read more about the article MIND CURE HEALTH INC. ANNOUNCES CLOSING OF THE FIRST TRANCHE OF LNG ENERGY GROUP’S SUBSCRIPTION RECEIPT FINANCING

MIND CURE HEALTH INC. ANNOUNCES CLOSING OF THE FIRST TRANCHE OF LNG ENERGY GROUP’S SUBSCRIPTION RECEIPT FINANCING

Post published:June 9, 2023
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.